Free Trial

Synthomer (LON:SYNT) Hits New 12-Month Low - Here's Why

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc hit a new 12-month low during trading, reaching GBX 56.80 ($0.76), with a recent close at GBX 57.20 ($0.77).
  • Several analysts downgraded their ratings and target prices for Synthomer, with JPMorgan reducing their target from GBX 200 to GBX 120.
  • Insider buying activity was noted, as insiders purchased over 104,000 shares of the company's stock in recent transactions.
  • Interested in Synthomer? Here are five stocks we like better.

Synthomer plc (LON:SYNT - Get Free Report) reached a new 52-week low during trading on Friday . The stock traded as low as GBX 56.80 ($0.76) and last traded at GBX 57.20 ($0.77), with a volume of 887189 shares traded. The stock had previously closed at GBX 59.60 ($0.80).

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. JPMorgan Chase & Co. cut their target price on shares of Synthomer from GBX 200 to GBX 120 and set a "neutral" rating for the company in a research note on Friday, October 10th. Berenberg Bank reduced their price objective on shares of Synthomer from GBX 120 to GBX 80 and set a "hold" rating for the company in a report on Wednesday, August 6th. Jefferies Financial Group reissued a "hold" rating and set a GBX 100 price target on shares of Synthomer in a report on Tuesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of Synthomer from GBX 140 to GBX 115 and set a "hold" rating for the company in a research report on Wednesday, July 30th. Four analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of GBX 103.75.

View Our Latest Stock Analysis on Synthomer

Synthomer Trading Down 4.0%

The company's fifty day simple moving average is GBX 65.05 and its two-hundred day simple moving average is GBX 85.77. The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 78.27. The company has a market capitalization of £93.51 million, a price-to-earnings ratio of -111.94, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79.

Synthomer (LON:SYNT - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported GBX (5.40) earnings per share for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. Research analysts forecast that Synthomer plc will post 12.962963 earnings per share for the current fiscal year.

Insider Buying and Selling at Synthomer

In related news, insider Uwe Halder purchased 25,000 shares of the business's stock in a transaction on Thursday, August 7th. The shares were purchased at an average price of GBX 64 per share, with a total value of £16,000. Also, insider Jonathan Silver purchased 59,229 shares of the business's stock in a transaction on Wednesday, August 6th. The stock was bought at an average cost of GBX 65 per share, for a total transaction of £38,498.85. Over the last quarter, insiders have purchased 104,229 shares of company stock valued at $6,729,885. 4.99% of the stock is currently owned by corporate insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.